Skip to content

Procter & Gamble stock

PGNYSE

The Procter & Gamble Company, Consumer DefensiveISIN US7427181091

$168.03▲ $0.36 (+0.2%)Closing price of 12 Nov 2026

72Score 72 out of 100, Strong

Turn on early warning

Price and trend

82 / 100

Price history

+14% in one year

The chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.

Long-term trend

Above the 200-day line: the price is 12% above it.

Trend change

Since October 2026 the 50-day line has been above the 200-day line; the trend has turned up.

Momentum

Normal: the price is neither overheated nor sold off (RSI 66).

Distance to the high

The price is at its 52-week high. Largest decline in 20 years: 41% (December 2007 to March 2009).

Chart figures for advanced users
SMA 50$153.80
Average price of the last 50 trading days, shows the short-term trend.
SMA 200$149.78
Average price of the last 200 trading days, shows the long-term trend.
RSI (14)66
Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
MACDabove the signal line
Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
Support$138.04
The lowest closing price of the last twelve months.
Resistance$168.66
The highest closing price of the last twelve months.
Market cap
$389.46B
Div. yield
2.57%
12 months
25.2
23.6
on earnings for the next twelve months ($7.13 per share)
Fair value
$149.38

Snapshot

Computed from the data by fixed rules, no AI

  • The Procter & Gamble Company belongs to the Household & Personal Products industry (United States) and, with a market value of $389.46B, is the largest of 39 companies in its industry on MEQIRI.
  • In fiscal 2026 it reported revenue of $87.03B (up 3.3% year on year) and earnings of $16.05B (up 0.5%).
  • For fiscal 2027, analysts expect on average revenue of $89.96B (up 3.4%) and adjusted earnings per share of $6.98 (up 1.2%).
Show more
  • MEQIRI Score 72 out of 100 (Strong): rank 45 of 296 in Consumer Defensive, median 62.
  • The P/E is 25.2 (Household & Personal Products median 23.8, own median of recent years 23.8).
  • Our model puts fair value at $149.38, with the price 12% above it.

In plain words

The numbers on this page in plain words, written by an AI

Strengths

  • Reliable dividendNo dividend cut for over 56 years.Capital allocation 81
  • Consistently profitableProfit in all 10 fiscal years from 2017 to 2026.Fundamentals 92
  • High return on capitalReturn on invested capital 19.8% in fiscal 2026, Household & Personal Products median 9%.Profitability 87

Weaknesses

None of our weakness checks flags anything. Crash risk is measured separately.

72/ 100
MEQIRI Score
Strong

Its standout strengths are fundamentals and profitability, while valuation and growth hold the score back.

Daily figure as of 13 Nov 2026

How the score is calculated

Score overview

Score since yesterday from 73 to 72.

Fundamentals are strong, with stable profits and strong cash generation.

Profit consistency100% of years
Cash conversion (free cash flow to earnings, 12 months)96%
ROIC (12 months)19.8%
Positive free cash flow100% of years
How this category is measured

Score history

The full history of up to 20 years comes with MEQIRI Pro.

See plans

Crash risk low

How well MEQIRI warns

One of the 30% with the lowest crash risk among the 100 largest stocks.

From 2016 to 2025, 4 in 100 such stocks fell 30% or more within a year, against a group average of 9 in 100.

What lowers it

  • solid fundamentals
  • very large company
  • price near its 52-week high

Valuation

Valuation signal

Modestly overvalued
Price
$168.03
Fair value
$149.38
Gap to fair value
+12%

In our model the price counts as cheap below $124.48 and expensive above $186.72 (uncertainty low, based on the price swings of the past year).

The two parts of the fair value come to $140.56 (cash-flow model) and $158.19 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is above both.

Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $137.54, at 7.8% it would be $167.13.

Valuation metrics

7.24
17.5
Fair value (model)
$149.38
Earnings part $158.19 (earnings per share $6.66 × 23.8)

Half from the cash-flow model, half from earnings times the industry P/E (23.8).

Calculate with your own assumptions

Company performance

This shows several years of history with an automatic assessment.

Revenue

20 years

In the twelve months to 30 Sep 2026, revenue rose 3.5% on the twelve months before. Revenue has stayed largely stable since 2007.

Margins

20 years
  • Gross margin
  • Operating margin
  • Net margin

In fiscal 2026: gross 50%, operating 23%, net 18%.

Debt & balance sheet

latest quarter
0.7
24.2x
0.72
Cash & equivalents
$15.37B

The balance sheet is solid, with moderate debt and comfortable interest coverage.

Earnings

Next earnings
21 Jan 2027in 69 days
Last reported
22 Oct 2026EPS reported $2.00 (expected $1.88)above expectations

Analyst estimates

Earnings estimates have barely changed since 15 Oct 2026.

Fiscal 202715 analysts
Earnings per share
$6.980.0%
Revenue
$89.96B+1.3%
Fiscal 202815 analysts
Earnings per share
$7.40+0.2%
Revenue
$92.75B+1.6%

MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.

Company outlook lowered

Share price after the results: −3.3%

Fiscal 2027 guidance of 1% to 3% organic sales growth with a roughly $1.4 billion earnings headwind ($0.56 per share) and first quarter EPS down 5% or more versus last year.

Supporting passage from the call, verbatim
“Combined, input costs, foreign exchange rate items, and items below the operating line, will be roughly a $1.4 billion after tax of earnings headwind in fiscal 2027, or $0.56 per share, 8% of fiscal 2026 core EPS.”

The outlook is not part of the score and not a recommendation to buy or sell.

From the earnings call on 29 Jul 2026 (fiscal Q4 2026), read by AI.

Insiders

Open-market purchases and sales by executives, board members and major holders

All insider purchases

No open-market purchases in the last 6 months. 12 insiders sold, $38.45M in total.

Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.

  • Abd El Hak HeshamSale

    12 Nov 2026, CEO-Baby and Feminine Care

    Shares
    2,250
    Price
    $168.47
    Value
    $379,058
  • Schulten AndreSale

    5 Nov 2026, Chief Financial Officer

    Shares
    30,677
    Price
    $169.00
    Value
    $5.18M
  • Santos de Azevedo Juliana MonteiroSale

    5 Nov 2026, CEO - Grooming

    Shares
    5,370
    Price
    $169.00
    Value
    $907,530
Show 26 more
  • Schulten AndreSale

    4 Nov 2026, Chief Financial Officer

    Shares
    33,624
    Price
    $165.00
    Value
    $5.55M
  • Janzaruk Matthew W.Sale

    3 Nov 2026, SVP - Chief Accounting Officer

    Shares
    9,479
    Price
    $163.00
    Value
    $1.55M
  • Gama PaulSale

    30 Oct 2026, CEO- Health Care

    Shares
    2,894
    Price
    $165.00
    Value
    $477,510
  • Aguilar Moses Victor JavierSale

    30 Oct 2026, Chf Rsch, Dev & Innov Officer

    Shares
    18,812
    Price
    $164.43
    Value
    $3.09M
  • Raman Sundar G.Sale

    30 Oct 2026, CEO-Fabric Home & Habitat Care

    Shares
    38,253
    Price
    $165.00
    Value
    $6.31M
  • Jejurikar ShaileshSale

    23 Oct 2026, Chairman, President and CEO

    Shares
    35,000
    Price
    $163.09
    Value
    $5.71M
  • Purushothaman BalajiSale

    23 Oct 2026, Chief Human Resources Officer

    Shares
    4,181
    Price
    $160.71
    Value
    $671,929
  • Gama PaulSale

    23 Oct 2026, CEO- Health Care

    Shares
    4,331
    Price
    $161.27
    Value
    $698,460
  • Schulten AndreSale

    5 Oct 2026, Chief Financial Officer

    Shares
    3,914
    Price
    $145.34
    Value
    $568,861
  • Gama PaulSale

    5 Oct 2026, CEO- Health Care

    Shares
    2,225
    Price
    $145.34
    Value
    $323,382
  • Whaley Susan StreetSale

    5 Oct 2026, Chief Legal Officer & Secy

    Shares
    2,369
    Price
    $145.34
    Value
    $344,310
  • Janzaruk Matthew W.Sale

    24 Aug 2026, SVP - Chief Accounting Officer

    Shares
    359
    Price
    $145.24
    Value
    $52,141
  • Raman Sundar G.Sale

    21 Aug 2026, CEO-Fabric Home & Habitat Care

    Shares
    3,435
    Price
    $143.02
    Value
    $491,274
  • Aguilar Moses Victor JavierSale

    20 Aug 2026, Chf Rsch, Dev & Innov Officer

    Shares
    3,053
    Price
    $143.79
    Value
    $438,991
  • Abd El Hak HeshamSale

    20 Aug 2026, CEO-Baby and Feminine Care

    Shares
    1,936
    Price
    $143.79
    Value
    $278,377
  • Santos de Azevedo Juliana MonteiroSale

    20 Aug 2026, CEO - Grooming

    Shares
    2,368
    Price
    $143.79
    Value
    $340,495
  • Janzaruk Matthew W.Sale

    20 Aug 2026, SVP - Chief Accounting Officer

    Shares
    156
    Price
    $143.79
    Value
    $22,431
  • Schulten AndreSale

    20 Aug 2026, Chief Financial Officer

    Shares
    5,402
    Price
    $143.79
    Value
    $776,754
  • Bharucha Freddy P.Sale

    20 Aug 2026, CEO - Beauty

    Shares
    246
    Price
    $143.79
    Value
    $35,372
  • Purushothaman BalajiSale

    20 Aug 2026, Chief Human Resources Officer

    Shares
    2,019
    Price
    $143.79
    Value
    $290,312
  • Jejurikar ShaileshSale

    20 Aug 2026, Chairman, President and CEO

    Shares
    6,176
    Price
    $143.79
    Value
    $888,047
  • Gama PaulSale

    20 Aug 2026, CEO- Health Care

    Shares
    3,396
    Price
    $143.79
    Value
    $488,311
  • Whaley Susan StreetSale

    20 Aug 2026, Chief Legal Officer & Secy

    Shares
    2,238
    Price
    $143.79
    Value
    $321,802
  • Pritchard Marc S.Sale

    20 Aug 2026, Chief Brand Officer

    Shares
    4,030
    Price
    $143.79
    Value
    $579,474
  • Aguilar Moses Victor JavierSale

    19 Aug 2026, Chf Rsch, Dev & Innov Officer

    Shares
    3,053
    Price
    $143.79
    Value
    $438,991
  • Whaley Susan StreetSale

    18 Aug 2026, Chief Legal Officer & Secy

    Shares
    8,644
    Price
    $144.00
    Value
    $1.24M

Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.

What happened at Procter & Gamble

The key events of the last six months from our own data. A click takes you to the matching card.

Sector comparison

296 rated companies in Consumer Defensive

Rank 45 of 296
45/ 296
This company
72
Sector median
62

Categories against the sector median

ProfitabilityMedian of 296 companies87 (median 54)33 above the median
GrowthMedian of 296 companies39 (median 50)11 below the median
FundamentalsMedian of 296 companies92 (median 79)13 above the median
ValuationMedian of 291 companies with a value41 (median 65)24 below the median
StabilityMedian of 296 companies74 (median 68)6 above the median
Capital allocationMedian of 296 companies81 (median 62)19 above the median
Technical analysisMedian of 296 companies82 (median 64)18 above the median
MomentumMedian of 296 companies75 (median 59)16 above the median

The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.

Competitors in Household & Personal Products

The next smaller companies by market value

All 39 Household & Personal Products stocks

ETFs that hold Procter & Gamble

Held by 119 ETFs on Xetra. Shown per index: the ETF with the largest weight.

Show 5 more

Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).

Data status and sources

Score
Daily value of 13 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2026, period end 30 Jun 2026
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Strong, published since 7 Nov 2026 (in the score history since 23 Oct 2026)
  • Valuation signal Fairly valued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy